Patent Foramen Ovale after Cryptogenic Stroke — Assessing the Evidence for Closure

The Amplatzer PFO Occluder was approved by the Food and Drug Administration (FDA) on October 28, 2016. The device is indicated for percutaneous transcatheter closure of a patent foramen ovale to reduce the risk of recurrent ischemic stroke in patients who've had a cryptogenic stroke that a…

http://ift.tt/2fkSbU9